Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Abbott Laboratories' Cash Machine Slowing Down?
Motley Fool
Wednesday, September 14, 2011 - 10:16am
tags:
Abbott Laboratories
New PDUFA Changes FDA Panels: Mike Explains
Pharmalot
Tuesday, September 13, 2011 - 2:24pm
tags:
FDA, PDUFA, advisory panels
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Minyanville
Tuesday, September 13, 2011 - 2:18pm
tags:
Merck, Eli Lilly, Amylin, diabetes, Bydureon, Alkermes, Victoza, Byetta, Novo Nordisk
Novartis Aims to Beat $1.9B in Cost Savings By Year's End
Motley Fool
Tuesday, September 13, 2011 - 2:16pm
tags:
Novartis, CIBA Vision, Alcon
Pfizer extends tender offer for Icagen shares
Yahoo/AP
Tuesday, September 13, 2011 - 2:15pm
tags:
Pfizer, Icagen, tender offer
Pfizer, Bayer others settle drug price allegations in Pa.
Bizjournals.com
Tuesday, September 13, 2011 - 2:15pm
tags:
Bayer, Pfizer, Pennsylvannia, drug pricing
What's Bad For Bisphosphonates Is Good For Emisphere
Seeking Alpha
Tuesday, September 13, 2011 - 10:18am
tags:
Emisphere, bisphosphonates, Amgen, Merck, Novartis, Roche, Sanofi
Novo Says More Patients Helped by Victoza When Diabetes Is Tackled Early
Bloomberg
Tuesday, September 13, 2011 - 10:16am
tags:
Victoza, diabetes, Novo Nordisk
Biocon Rises After Starting Manufacture of Lipitor Ingredients
Bloomberg
Tuesday, September 13, 2011 - 10:16am
tags:
Biocon, Lipitor, Pfizer, Malaysia
Medivation Remains Neutral
Yahoo/Zacks.com
Tuesday, September 13, 2011 - 10:15am
tags:
Medivation, JNJ, Pfizer, dimebon, Alzheimer's disease, prostate cancer, MDV3100
Is United Therapeutics Earning Its Keep?
Motley Fool
Tuesday, September 13, 2011 - 10:13am
tags:
United Therapeutics, Pfizer, Teva Pharmaceuticals, GSK
Lilly/Amylin diabetes drug shows promise
Yahoo/InvestorsBusinessDaily
Tuesday, September 13, 2011 - 10:12am
tags:
Eli Lilly, Amylin, Bydureon, diabetes
Commonly Used Pain Pills Increase Kidney Cancer Risk in Study
Bloomberg
Monday, September 12, 2011 - 5:48pm
tags:
kidney cancer, ibuprofen, JNJ, Pfizer, Bayer, naproxen
GSK Sues to Block Generic BPH Drugs From Mylan, Impax
Motley Fool
Monday, September 12, 2011 - 5:39pm
tags:
GSK, generics, Mylan, Impax, benign prostatic hyperplasia, BPH
Bristol-Myers Takes Over Amira Pharma
Yahoo/Zacks.com
Monday, September 12, 2011 - 5:36pm
tags:
Amira, Bristol-Myers Squibb, M&A, Sanofi
Is Dendreon a Turnaround Candidate?
Motley Fool
Monday, September 12, 2011 - 5:35pm
tags:
Dendreon, layoffs, Provenge, prostate cancer
SuperGen changes name to Astex Pharma after deal
Yahoo/AP
Monday, September 12, 2011 - 5:34pm
tags:
Supergen, Astex
7 Cheap Biotechs That Could Double Or Triple By Next Year
Seeking Alpha
Monday, September 12, 2011 - 1:28pm
tags:
Inhibitex, Optimer, Catalyst, Rexahn, Keryx, BioSante, Aeterna Zentaris
Questcor falls on slower new Acthar prescriptions
Yahoo/AP
Monday, September 12, 2011 - 1:26pm
tags:
Questcor, Acthar, MS, multiple sclerosis
InterMune is Latest Biotech to Test Investors' Stomach for a Drug Launch
Minyanville
Monday, September 12, 2011 - 1:25pm
tags:
InterMune, Esbriet, Europe

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.